LAMISIL SOLUTION Trademark

Trademark Overview


On Friday, May 4, 2007, a trademark application was filed for LAMISIL SOLUTION with the United States Patent and Trademark Office. The USPTO has given the LAMISIL SOLUTION trademark a serial number of 77172913. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 23, 2009. This trademark is owned by Novartis AG. The LAMISIL SOLUTION trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines
lamisil solution

General Information


Serial Number77172913
Word MarkLAMISIL SOLUTION
Filing DateFriday, May 4, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 23, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2007

Trademark Statements


Disclaimer with Predetermined Text"SOLUTION"
Goods and ServicesDiagnostic preparations for medical and veterinary use; Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 8, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, February 23, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 23, 2009ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 16, 2008EXTENSION 1 GRANTED
Wednesday, July 16, 2008EXTENSION 1 FILED
Wednesday, July 16, 2008TEAS EXTENSION RECEIVED
Tuesday, January 22, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2007NOTICE OF PUBLICATION
Sunday, September 23, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, September 23, 2007ASSIGNED TO LIE
Saturday, August 18, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 17, 2007EXAMINER'S AMENDMENT ENTERED
Friday, August 17, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 17, 2007EXAMINERS AMENDMENT E-MAILED
Friday, August 17, 2007EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 14, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 14, 2007NON-FINAL ACTION E-MAILED
Tuesday, August 14, 2007NON-FINAL ACTION WRITTEN
Monday, August 13, 2007ASSIGNED TO EXAMINER
Tuesday, May 8, 2007NEW APPLICATION ENTERED IN TRAM